SCHEMBL7990043

SCHEMBL7990043

COc1cc(Nc2ccccc2)c([N+](=O)[O-])cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.57
TDP1 Q9NUW8 5/20 0.57
L3MBTL1 Q9Y468 4/20 0.57
MAPK1 P28482 4/20 0.57
CASP7 P55210 1/20 0.57
HCAR3 P49019 1/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
MAPT P10636 7/20 0.52
POLB P06746 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP3A4 P08684 1/20 0.51
TSHR P16473 1/20 0.51
AKR1C3 P42330 2/20 0.50
AKR1C2 P52895 2/20 0.50
AKR1B10 O60218 1/20 0.50
AKR1B1 P15121 1/20 0.50
AKR1C4 P17516 1/20 0.50
AKR1C1 Q04828 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976555 0.90 TDP1 (0.54) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL7949126 0.89 L3MBTL1 (0.58) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL31621042 0.89 ALDH1A1 (0.51) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL9943157 0.82 L3MBTL1 (0.70) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL2212705 0.81 AKR1C3 (0.68) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL6179431 0.81 AKR1C3 (0.74) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL27470880 0.79 MEN1 (0.70) ALDH1A1TDP1L3MBTL1MAPK1CASP7
SCHEMBL9537129 0.78 MAPT (0.60) ALDH1A1TDP1L3MBTL1MAPK1MEN1
SCHEMBL11331546 0.78 MAPT (0.62) ALDH1A1TDP1L3MBTL1MAPK1MEN1
SCHEMBL10813693 0.77 HCAR3 (0.52) ALDH1A1TDP1L3MBTL1MAPK1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed